Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Dec 18;284(51):35308-13.
doi: 10.1074/jbc.M109.078261.

Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade

Affiliations

Phosphatidylinositol 3-kinase signaling does not activate the wnt cascade

Ser Sue Ng et al. J Biol Chem. .

Abstract

Mutational activation of the phosphatidylinositol 3-kinase (PI3K) pathway occurs in a wide variety of tumors, whereas activating Wnt pathway mutants are predominantly found in colon cancer. Because GSK3 is a key component of both pathways, it is widely assumed that active PI3K signaling feeds positively into the Wnt pathway by protein kinase B (PKB)-mediatefd inhibition of GSK3. In addition, PKB has been proposed to modulate the canonical Wnt signaling through direct stabilization and nuclear localization of beta-catenin. Here, we show that compartmentalization by Axin of GSK3 prohibits cross-talk between the PI3K and Wnt pathways and that Wnt-mediated transcriptional activity is not modulated by activation of the PI3K/PKB pathway.

PubMed Disclaimer

Figures

FIGURE 1.
FIGURE 1.
Wnt ligands, β-catenin, and LiCl induce TCF/β-catenin-dependent transcription in PC3 (A), BT549 (B), LNCaP (C), and MDA-MB-468, (D) cell lines in a PI3K/Akt-independent manner. Cells were plated at 50–60% confluency in 24-well plates and transfected with pTOPFlash reporters, with or without Wnt1, Wnt3A, β-catenin, or TCF4 plasmids as indicated. 20 mm LiCl, 100 nm (BT509) or 250 nm (PC3, LNCaP, and MDA-MB-468) PI3K-inhibitor wortmannin, and 50 nm Akt inhibitor IV were added as indicated 16 h following transfection, and measurements were done after 24 h. The TOPFlash data (top panel) are representative of at least two independent experiments. Error bars represent ± S.D. Effective inhibition of the PI3K/PKB pathway in response to wortmannin and Akt inhibitor IV treatment is shown by Western blotting as indicated in the panels below the pertinent bar graphs.
FIGURE 2.
FIGURE 2.
PI3K/PKB pathway activity does not modulate Wnt/β-catenin signaling through GSK3β. A, mouse monoclonal A5 antibody is Axin1-specific, whereas A6 antibody recognizes both Axin1 and Conductin. 0.5 μg of DNA/well were transfected into HEK293T cells in a 6-well plate. All samples were lysed in 2× SDS sample buffer after 24 h, and Western blot analysis was performed using anti-FLAG, A6, and A5 antibodies, respectively. B–D, activation of PI3K/PKB pathway does not influence the phosphorylated or total amount of GSK3β protein that is bound to AXIN. HEK293T cells were cultured in 5% fetal calf serum/RPMI 1640 medium to 80% confluency and then starved in serum-free medium for at least 12 h before treatment with 10 mg/liter insulin for 10 and 30 min (B) and 1 and 4 h (C) or 200 nm wortmannin for 30 min (B) and 1 and 4 h (D). Cells were lysed and immunoprecipitated (IP) with either control mouse IgG or anti-Axin antibody. Resulting immunocomplexes were subjected to immunoblotting (IB) using the indicated antibodies.
FIGURE 3.
FIGURE 3.
Tcf/β-catenin transcriptional activity is not modulated by activation of the PI3K/PKB pathway. HEK293T cells were plated at 30–40% confluency in 24-well plates and transfected with pTOPFlash reporters, Wnt3a and Dkk1 (Wnt inhibitor) plasmids as indicated. 16 h after transfection, half of the cells were starved with serum-free medium for at least 12 h before treatment with 20 mm LiCl, 10 mg/liter insulin, or 200 nm wortmannin as indicated. Measurement was done another 16–24 h later. Incubation periods of the nonstarved cells were the same for the starved cells. Data are from three independent duplicate experiments (except ★, n = 2). Error bars indicate mean ± S.D.

References

    1. Kockeritz L., Doble B., Patel S., Woodgett J. R. (2006) Curr. Drug Targets 7, 1377–1388 - PubMed
    1. Cully M., You H., Levine A. J., Mak T. W. (2006) Nat. Rev. Cancer 6, 184–192 - PubMed
    1. Cross D. A., Alessi D. R., Cohen P., Andjelkovich M., Hemmings B. A. (1995) Nature 378, 785–789 - PubMed
    1. Sutherland C., Cohen P. (1994) FEBS Lett. 338, 37–42 - PubMed
    1. Sutherland C., Leighton I. A., Cohen P. (1993) Biochem. J. 296, 15–19 - PMC - PubMed

MeSH terms